Runs medical studies that test new drugs for drug companies.
Sold some
Fundsmith still owns 52,372 shares of Medpace, worth about $28 million, or less than $1 of every $100 they have in stocks. Between April and June they sold 10,296 shares (down 16%).
Mar 31
62,668
Jun 30
52,372
The numbers
Shares they own
52,372
Change since Mar 31
−10,296
−16.4%
Shares on Mar 31
62,668
Value on Jun 30, 2026
$27,735,687
about $28 million
Share of their money
0.2%
less than $1 of every $100 · 26th of 41
Price per share on Jun 30
$529.59
Value of the shares they sold
about $5 million
at the Jun 30 price
Kind
Shares
More about Medpace ›
The value uses the price on Jun 30, 2026. The fund may have paid a different price.